Haifa, Israel (PRWEB) November 07, 2012
OHK Medical Devices Ltd., manufacturer of the HemaClear® single-use, sterile exsanguinating tourniquet device, announced today that it has further expanded its European business activity. The company has entered an exclusive distribution agreement in France with Provin Medical. OHK and Provin will formally launch their entry into these markets at the Société Française de Chirurgie Orthopédique et Traumatologique, (SOFCOT) Annual Scientific Meeting to be held in Paris between 12-16 of November, 2012. During the meeting the companies will hold three surgeon workshops to be hosted by international surgeons who use HemaClear in their daily practice. These seminars will take place on the 14th of November at the exhibition grounds. For further information and reservations please contact OHK at info(at)hemaclear(dot)com or Provin Medical at info(at)provinmedical(dot)fr. Visit HemaClear at booth #N21 to receive a free trial kit.
“We are very excited to enter one of the largest and most important European markets”, said Oren Gavriely, CEO, OHK Medical Devices. Gavriely added that “The introduction of HemaClear in France is an important step in further establishing HemaClear® as a worldwide standard of care tourniquet technology for bloodless surgery, improving clinical outcomes and saving hospitals time and money.”
“This exciting tourniquet technology represents the first advance in tourniquets in more than 100 years”, said David Chaouat, Managing Director, Provin Medical. “HemaClear has already been generating strong interest nationwide – not only from some of the leading orthopedic surgeons but also from the vascular surgery field”, Chaouat added.
HemaClear® is the world’s leading sterile tourniquet with a simple yet innovative technology, representing a new standard of care in bloodless orthopedic surgery. Since entering the market in 2007 this product has been successfully used in almost 500,000 procedures. Easier, cheaper and safer than the standard offerings, HemaClear® represents the first significant advancement in tourniquet technology in over 100 years. HemaClear® was developed by OHK Medical Devices (OHK), a privately held company based in Haifa, Israel and the United States and is currently used in over 2000 operating rooms across 30 countries. For more information about HemaClear®, visit http://www.hemaclear.com.
About Provin Medical
Provin Medical is a start up company, based in Lyon, France.. Its purpose is to promote the medical innovation in a hospital environment and privilege the optimization of procedures to the advantages of the care and the safety of the patient, in particular by the deployment of high efficient sterile and single-use devices. Provin Medical has selected HemaClear because it combines safety and high performance innovation with an applicable market of more than 1.5 million surgical procedures in France per year. For more information contact: info(at)provinmedical(dot)fr.